{"schema_version":"secwatch.filing_event.v1","accession":"0001564590-22-010637","form_type":"8-K","ticker":"TRVI","cik":"0001563880","company_name":"Trevi Therapeutics, Inc.","filed_at":"2022-03-16T23:59:59+00:00","discovered_at":"2026-05-14T18:04:07.002777+00:00","generated_at":"2026-06-26T22:21:25.466182+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Trevi Therapeutics regains Nasdaq minimum bid price compliance","bullets":["Received Nasdaq deficiency letter on Jan 10, 2022 for bid price below $1 for 30 consecutive days.","Compliance regained after closing bid price above $1 for ten consecutive business days (March 2-15, 2022).","Nasdaq notified company on March 16, 2022 that the matter is closed.","Company's common stock remains listed on Nasdaq Global Market."],"urls":{"canonical":"https://secwatch.observer/filing/0001564590-22-010637","json":"https://secwatch.observer/filing/0001564590-22-010637.json","markdown":"https://secwatch.observer/filing/0001564590-22-010637.md","text":"https://secwatch.observer/filing/0001564590-22-010637.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1563880/000156459022010637/0001564590-22-010637-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1563880/000156459022010637/trvi-8k_20220316.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T22:21:25.466182+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}